Quantcast
Channel: MedHeadlines » rofecoxib
Browsing all 2 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Hired Writers, Not Scientists, Behind Merck’s Vioxx Studies

In a new twist to the ethical issues Merck Inc, faces over Vioxx (rofecoxib), the company’s one-time best seller that was pulled from the market in 2004, because it became closely associated with...

View Article



Image may be NSFW.
Clik here to view.

Bad News, Good News on Vioxx Heart Attack Risk

Long-term study of individuals taking Vioxx (rofecoxib) for arthritis and chronic pain has confirmed some bad news associated with the painkiller but it has revealed some good news, too.  Vioxx, a...

View Article
Browsing all 2 articles
Browse latest View live


Latest Images